Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma

BJU International

Volumn 109, Issue 1, 2012, Pages 77-82

  Favaretto, Ricardo L ^a   Shariat, Shahrokh F ^a   Savage, Caroline ^a   Godoy, Guilherme ^a   Chade, Daher C ^a   Kaag, Matthew ^a   Bochner, Bernard H ^a   Coleman, Jonathan ^a   Dalbagni, Guido ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

nephroureterectomy; prognosis; renal pelvis; transitional cell carcinoma; urothelial carcinoma

Indexed keywords

ACCURACY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HYDRONEPHROSIS; IMAGE ANALYSIS; IMAGING; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE UPPER TRACT UROTHELIAL CARCINOMA; NEPHROURETERECTOMY; NON ORGAN CONFINED UPPER TRACT UROTHELIAL CARCINOMA; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TRANSITIONAL CELL CARCINOMA; TUMOR LOCALIZATION; URETEROSCOPY;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; URETEROSCOPY; UROLOGIC NEOPLASMS; YOUNG ADULT;

EID: 83555166303     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10288.x     Document Type: Article

References (33)

1. Lughezzani G, Jeldres C, Isbarn H, et al,. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. Eur J Cancer 2009; 45: 3291-7
2. Margulis V, Shariat SF, Matin SF, et al,. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115: 1224-33
3. Huben RP, Mounzer AM, Murphy GP,. Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 1988; 62: 2016-20 (Pubitemid 18261830)
4. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG,. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998; 52: 594-601 (Pubitemid 28440164)
5. Roscigno M, Cozzarini C, Bertini R, et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol 2008; 53: 794-802
6. Kikuchi E, Margulis V, Karakiewicz PI, et al,. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009; 27: 612-8
7. Remzi M, Haitel A, Margulis V, et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 2009; 103: 307-11
8. Zigeuner R, Shariat SF, Margulis V, et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 2010; 57: 575-81
9. Raman JD, Ng CK, Scherr DS, et al,. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 2010; 57: 1072-9
10. Roscigno M, Shariat SF, Margulis V, et al,. Theextent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 2009; 56: 512-8
11. Fernandez MI, Shariat SF, Margulis V, et al,. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: Results of large multicenter study. Urology 2009; 73: 142-6
12. Waldert M, Karakiewicz PI, Raman JD, et al,. A delay in radical nephroureterectomy can lead to upstaging. BJU Int 2010; 105: 812-7
13. Shariat SF, Godoy G, Lotan Y, et al,. Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 2010; 105: 1672-7
14. Ng CK, Shariat SF, Lucas SM, et al,. Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma? Urol Oncol 2011; 29: 27-32
15. Lughezzani G, Sun M, Perrotte P, et al,. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: Results from the Surveillance, Epidemiology, and End Results Database. Urology 2010; 75: 321-7
16. Novara G, Matsumoto K, Kassouf W, et al,. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 2010; 57: 1064-71
17. Favaretto RL, Shariat SF, Chade DC, et al. The effect of tumorlocation on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 2010; 58: 574-80
18. Lee SE, Byun SS, Park YH, Chang IH, Kim YJ, Hong SK,. Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract. Urol Int 2006; 77: 22-6
19. Hellenthal NJ, Shariat SF, Margulis V, et al,. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: Results from the upper tract urothelial carcinoma collaboration. J Urol 2009; 182: 900-6
20. Lane BR, Smith AK, Larson BT, et al. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 2010; 116: 2967-73
21. Kaag MG, O'Malley RL, O'Malley P, et al,. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 2010; 58: 581-7
22. Grossman HB, Natale RB, Tangen CM, et al,. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859-66 (Pubitemid 37025405)
23. Moussa S, Yafi FA, El-Hakim A, et al,. Outcome of surgical treatment of patients with upper versus lower urinary tract urothelial carcinoma: stage-by-stage comparison. Urol Int 2010; 84: 50-5
24. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K,. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J Urol 2007; 178: 1212-7 (Pubitemid 47368417)
25. Epstein JI, Amin MB, Reuter VR, Mostofi FK,. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435-48 (Pubitemid 28550639)
26. Margulis V, Youssef RF, Karakiewicz PI, et al,. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 2010; 184: 453-8
27. Brien JC, Shariat SF, Herman MP, et al. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 2010; 184: 69-73
28. Buckley JA, Urban BA, Soyer P, Scherrer A, Fishman EK,. Transitional cell carcinoma of the renal pelvis: a retrospective look at CT staging with pathologic correlation. Radiology 1996; 201: 194-8 (Pubitemid 26314387)
29. Scolieri MJ, Paik ML, Brown SL, Resnick MI,. Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma. Urology 2000; 56: 930-4
30. Fritz GA, Schoellnast H, Deutschmann HA, Quehenberger F, Tillich M,. Multiphasic multidetector-row CT (MDCT) in detection and staging of transitional cell carcinomas of the upper urinary tract. Eur Radiol 2006; 16: 1244-52 (Pubitemid 43834710)
31. Keeley FX, Kulp DA, Bibbo M, McCue PA, Bagley DH,. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 1997; 157: 33-7 (Pubitemid 26414922)
32. Brown GA, Matin SF, Busby JE, et al,. Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology 2007; 70: 252-6 (Pubitemid 47362246)
33. Guarnizo E, Pavlovich CP, Seiba M, Carlson DL, Vaughan ED Jr, Sosa RE,. Ureteroscopic biopsy of upper tract urothelial carcinoma: simproved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol 2000; 163: 52-5